Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Physiomics ( (GB:PYC) ) is now available.
Physiomics has granted a total of 4,548,132 share options under its existing option scheme, including a new award of 4,548,132 options to Head of Biometrics Jesse Thissen, structured across three tranches with exercise prices set at substantial premiums to the current share price and vesting between July 2026 and July 2028. The Board positions the grant as a key retention and incentive tool as the company scales its biometrics service line, which has already secured three contracts within six months of Thissen’s appointment, supporting its wider strategy to drive growth and move towards cash generation.
Spark’s Take on GB:PYC Stock
According to Spark, TipRanks’ AI Analyst, GB:PYC is a Underperform.
Physiomics’ stock score is primarily impacted by significant financial instability, including declining revenues and negative profit margins. Technical indicators reinforce a bearish outlook. While recent corporate events suggest potential growth pathways, current valuation issues and financial challenges remain significant obstacles.
To see Spark’s full report on GB:PYC stock, click here.
More about Physiomics
Physiomics plc (AIM: PYC) is a UK-listed company that provides modelling and analytics services to the life sciences sector, with a growing focus on biometrics services that support the development of new therapies, including treatments for infectious and immunological diseases.
Average Trading Volume: 3,487,759
Technical Sentiment Signal: Sell
Current Market Cap: £864.1K
For an in-depth examination of PYC stock, go to TipRanks’ Overview page.